|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:AXIN1-MYO19 (FusionGDB2 ID:HG8312TG80179) |
Fusion Gene Summary for AXIN1-MYO19 |
Fusion gene summary |
Fusion gene information | Fusion gene name: AXIN1-MYO19 | Fusion gene ID: hg8312tg80179 | Hgene | Tgene | Gene symbol | AXIN1 | MYO19 | Gene ID | 8312 | 80179 |
Gene name | axin 1 | myosin XIX | |
Synonyms | AXIN|PPP1R49 | MYOHD1 | |
Cytomap | ('AXIN1')('MYO19') 16p13.3 | 17q12 | |
Type of gene | protein-coding | protein-coding | |
Description | axin-1axis inhibition protein 1axis inhibitor 1fused, mouse, homolog ofprotein phosphatase 1, regulatory subunit 49 | unconventional myosin-XIXmyosin head domain containing 1myosin head domain-containing protein 1 | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000262320, ENST00000354866, ENST00000481769, | ||
Fusion gene scores | * DoF score | 16 X 10 X 9=1440 | 8 X 9 X 5=360 |
# samples | 23 | 10 | |
** MAII score | log2(23/1440*10)=-2.6463630453853 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/360*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: AXIN1 [Title/Abstract] AND MYO19 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | AXIN1(354304)-MYO19(34867294), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | AXIN1-MYO19 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AXIN1-MYO19 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AXIN1-MYO19 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. AXIN1-MYO19 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | AXIN1 | GO:0001934 | positive regulation of protein phosphorylation | 9601641 |
Hgene | AXIN1 | GO:0032147 | activation of protein kinase activity | 9601641 |
Hgene | AXIN1 | GO:0034622 | cellular protein-containing complex assembly | 16601693 |
Hgene | AXIN1 | GO:0045732 | positive regulation of protein catabolic process | 9601641 |
Hgene | AXIN1 | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 10644691 |
Tgene | MYO19 | GO:0034642 | mitochondrion migration along actin filament | 19932026 |
Fusion gene breakpoints across AXIN1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across MYO19 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8296-01A | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
Top |
Fusion Gene ORF analysis for AXIN1-MYO19 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000262320 | ENST00000544606 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5CDS-intron | ENST00000262320 | ENST00000586007 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5CDS-intron | ENST00000262320 | ENST00000590081 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5CDS-intron | ENST00000354866 | ENST00000544606 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5CDS-intron | ENST00000354866 | ENST00000586007 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5CDS-intron | ENST00000354866 | ENST00000590081 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5UTR-3CDS | ENST00000481769 | ENST00000268852 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5UTR-3CDS | ENST00000481769 | ENST00000431794 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5UTR-intron | ENST00000481769 | ENST00000544606 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5UTR-intron | ENST00000481769 | ENST00000586007 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
5UTR-intron | ENST00000481769 | ENST00000590081 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
In-frame | ENST00000262320 | ENST00000268852 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
In-frame | ENST00000262320 | ENST00000431794 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
In-frame | ENST00000354866 | ENST00000268852 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
In-frame | ENST00000354866 | ENST00000431794 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000262320 | AXIN1 | chr16 | 354304 | - | ENST00000431794 | MYO19 | chr17 | 34867294 | - | 4263 | 1626 | 21 | 3644 | 1207 |
ENST00000262320 | AXIN1 | chr16 | 354304 | - | ENST00000268852 | MYO19 | chr17 | 34867294 | - | 3541 | 1626 | 21 | 3044 | 1007 |
ENST00000354866 | AXIN1 | chr16 | 354304 | - | ENST00000431794 | MYO19 | chr17 | 34867294 | - | 4053 | 1416 | 15 | 3434 | 1139 |
ENST00000354866 | AXIN1 | chr16 | 354304 | - | ENST00000268852 | MYO19 | chr17 | 34867294 | - | 3331 | 1416 | 15 | 2834 | 939 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000262320 | ENST00000431794 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - | 0.006166686 | 0.9938333 |
ENST00000262320 | ENST00000268852 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - | 0.007560293 | 0.99243975 |
ENST00000354866 | ENST00000431794 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - | 0.004553649 | 0.99544626 |
ENST00000354866 | ENST00000268852 | AXIN1 | chr16 | 354304 | - | MYO19 | chr17 | 34867294 | - | 0.006818679 | 0.9931813 |
Top |
Fusion Genomic Features for AXIN1-MYO19 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for AXIN1-MYO19 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:354304/chr17:34867294) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 88_211 | 418 | 863.0 | Domain | RGS |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 88_211 | 418 | 827.0 | Domain | RGS |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 20_29 | 418 | 863.0 | Motif | Note=Tankyrase-binding motif |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 20_29 | 418 | 827.0 | Motif | Note=Tankyrase-binding motif |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000268852 | 10 | 22 | 759_779 | 298 | 771.0 | Domain | IQ 1 | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000268852 | 10 | 22 | 783_812 | 298 | 771.0 | Domain | IQ 2 | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000431794 | 10 | 26 | 759_779 | 298 | 971.0 | Domain | IQ 1 | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000431794 | 10 | 26 | 783_812 | 298 | 971.0 | Domain | IQ 2 | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000586007 | 0 | 11 | 35_758 | 0 | 318.0 | Domain | Myosin motor | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000586007 | 0 | 11 | 759_779 | 0 | 318.0 | Domain | IQ 1 | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000586007 | 0 | 11 | 783_812 | 0 | 318.0 | Domain | IQ 2 | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000586007 | 0 | 11 | 132_139 | 0 | 318.0 | Nucleotide binding | ATP | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000268852 | 10 | 22 | 602_624 | 298 | 771.0 | Region | Actin-binding | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000268852 | 10 | 22 | 824_970 | 298 | 771.0 | Region | MyMOMA region | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000431794 | 10 | 26 | 602_624 | 298 | 971.0 | Region | Actin-binding | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000431794 | 10 | 26 | 824_970 | 298 | 971.0 | Region | MyMOMA region | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000586007 | 0 | 11 | 602_624 | 0 | 318.0 | Region | Actin-binding | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000586007 | 0 | 11 | 824_970 | 0 | 318.0 | Region | MyMOMA region |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 780_862 | 418 | 863.0 | Domain | DIX |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 780_862 | 418 | 827.0 | Domain | DIX |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000268852 | 10 | 22 | 35_758 | 298 | 771.0 | Domain | Myosin motor | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000431794 | 10 | 26 | 35_758 | 298 | 971.0 | Domain | Myosin motor | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000268852 | 10 | 22 | 132_139 | 298 | 771.0 | Nucleotide binding | ATP | |
Tgene | MYO19 | chr16:354304 | chr17:34867294 | ENST00000431794 | 10 | 26 | 132_139 | 298 | 971.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for AXIN1-MYO19 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>8563_8563_1_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000262320_MYO19_chr17_34867294_ENST00000268852_length(transcript)=3541nt_BP=1626nt CTCGGGAGGCGATCGTGGCCGCTGCCGCCGCCAGAGCCGGCCGGAGTCGGCCCGGAGCCGCGTCCACGCGGAGCGGGCGGGTGGGAGCTG GCGGCTGGGCCCCTGCGGCGCCCCCGCGGCCTGCCCCGCGTCCGCCTCCGGGCCGCCGAGCCGCAGCCGCCGAGATGGGGGCCGCCCCGG GCCGCGCCCCCGCCGGGTCCCGCCCGCCGCGCTGCCGCTGAGCGCATGGGCCCGGACCGCGCCGCGCCGCTCCGGGAGCCGGGCCCGGGG TCCCGCCACCACCGCGCGCGGGACAGATTGATTCACTTTGGAGCTGTAAGTACTGATGTATTAGGGTGCAGCGCTCATTGTTCCTTGACG CAGAGTCCCAAAATGAATATCCAAGAGCAGGGTTTCCCCTTGGACCTCGGAGCAAGTTTCACCGAAGATGCTCCCCGACCCCCAGTGCCT GGTGAGGAGGGAGAACTGGTGTCCACAGACCCGAGGCCCGCCAGCTACAGTTTCTGCTCCGGGAAAGGTGTTGGCATTAAAGGTGAGACT TCGACGGCCACTCCGAGGCGCTCGGATCTGGACCTGGGGTATGAGCCTGAGGGCAGTGCCTCCCCCACCCCACCATACTTGAAGTGGGCT GAGTCACTGCATTCCCTGCTGGATGACCAAGATGGGATAAGCCTGTTCAGGACTTTCCTGAAGCAGGAGGGCTGTGCCGACTTGCTGGAC TTCTGGTTTGCCTGCACTGGCTTCAGGAAGCTGGAGCCCTGTGACTCGAACGAGGAGAAGAGGCTGAAGCTGGCGAGAGCCATCTACCGA AAGTACATTCTTGATAACAATGGCATCGTGTCCCGGCAGACCAAGCCAGCCACCAAGAGCTTCATAAAGGGCTGCATCATGAAGCAGCTG ATCGATCCTGCCATGTTTGACCAGGCCCAGACCGAAATCCAGGCCACTATGGAGGAAAACACCTATCCCTCCTTCCTTAAGTCTGATATT TATTTGGAATATACGAGGACAGGCTCGGAGAGCCCCAAAGTCTGTAGTGACCAGAGCTCTGGGTCAGGGACAGGGAAGGGCATATCTGGA TACCTGCCGACCTTAAATGAAGATGAGGAATGGAAGTGTGACCAGGACATGGATGAGGACGATGGCAGAGACGCTGCTCCCCCCGGAAGA CTCCCTCAGAAGCTGCTCCTGGAGACAGCTGCCCCGAGGGTCTCCTCCAGTAGACGGTACAGCGAAGGCAGAGAGTTCAGGTATGGATCC TGGCGGGAGCCAGTCAACCCCTATTATGTCAATGCCGGCTATGCCCTGGCCCCAGCCACCAGTGCCAACGACAGCGAGCAGCAGAGCCTG TCCAGCGATGCAGACACCCTGTCCCTCACGGACAGCAGCGTGGATGGGATCCCCCCATACAGGATCCGTAAGCAGCACCGCAGGGAGATG CAGGAGAGCGTGCAGGTCAATGGGCGGGTGCCCCTACCTCACATTCCCCGCACGTACCGGGTGCCGAAGGAGGTCCGCGTGGAGCCTCAG AAGTTCGCGGAGGAGCTCATCCACCGCCTGGAGGCTGTGCAGCGCACGCGGGAGGCCGAGGAGAAGCTGGAGGAGCGGCTGAAGCGCGTG CGCATGGTCCTAGCTGGACTGCTGCACCTTGGCAATATCCAGTTTGCTGCCTCCGAGGATGAAGCCCAGCCCTGCCAGCCGATGGATGAT GCCAAGTACTCTGTCAGGACGGCAGCCTCGCTGCTGGGGCTCCCAGAGGACGTGCTGCTGGAGATGGTGCAGATTAGAACCATCAGGGCA GGCAGACAGCAGCAGGTGTTCCGGAAGCCCTGCGCCCGAGCCGAGTGTGACACCCGTAGAGACTGCCTGGCCAAACTGATCTATGCGCGG TTGTTTGACTGGCTGGTATCAGTGATCAACAGCAGCATCTGTGCAGACACCGACTCGTGGACCACTTTCATAGGCCTGCTGGATGTGTAT GGATTTGAATCATTTCCTGACAACAGTCTGGAACAGTTGTGCATCAACTACGCCAATGAGAAGCTCCAGCTGGAGGCCTGTGGCCTCGTG GAGACCATCCATATCAGTGCTGCTGGCTTCCCCATCCGGGTCTCTCACCGAAACTTTGTAGAACGATACAAGTTACTAAGAAGGCTTCAT CCTTGCACATCCTCTGGCCCCGACAGCCCATATCCTGCCAAAGGGCTCCCTGAATGGTGTCCACACAGCGAGGAAGCCACGCTTGAACCT CTCATCCAGGACATTCTCCACACTCTGCCGGTCCTAACTCAGGCAGCAGCCATAACTGGTGACTCGGCTGAGGCCATGCCAGCCCCCATG CACTGTGGCAGGACCAAGGTGTTCATGACTGACTCTATGCTGGAGCTTCTGGAATGTGGGCGTGCCCGGGTGCTGGAGCAGTGTGCCCGC TGCATCCAGGGTGGCTGGAGGCGACACCGGCACCGAGAGCAGGAGCGGCAGTGGCGGGCCGTCATGCTCATCCAGGCAGCCATTCGTTCC TGGTTAACTCGGAAACACATCCAGAGGCTGCATGCAGCTGCCACAGTCATCAAGCGTGCATGGCAGAAGTGGAGAATCAGAATGGCCTGC CTTGCTGCTAAAGAGCTGGATGGTGTGGAAGAAAAACACTTCTCTCAAGCTCCCTGTTCCCTGAGCACCTCGCCGCTGCAGACCAGGCTC CTGGAGGCAATAATCCGCCTCTGGCCCCTGGGACTGGTCCTGGCCAATACGGCTATGGGTGTAGGCAGCTTTCAGAGGAAATTAGTGGTC TGGGCTTGCCTCCAGCTCCCCAGGGGCAGCCCCAGTAGCTACACTGTCCAGACAGCACAAGACCAGGCTGGTGTCACGTCCATCCGAGCG CTGCCTCAGGGATCGATAAAGTTTCACTGCAGAAAGTCTCCACTGCGGTATGCTGACATCTGCCCTGAACCTTCACCCTACAGCATTACA GGCTTTAATCAGATTCTGCTGGAAAGACACAGGCTGATCCACGTGACCTCTTCTGCCTTCACTGGGCTGGGGTGATCCTTGGTGCCTTTG TTTCCACAAGGCCTTTTCCTGCCCCCTGCCTTGCCAAAGACATTTAATCAGCACACAGCTGCCAGACTATTCCCACAGTGCTCCAAATGC ACATGAACAACAGTGACGGCTCCAGCCTTCGACCCAGAGCCCCGTGCCCAGTGCGTCAGTGGGCCTGGGGTTCCAGGCTACATCAAGCAC TGATGGTGTCAGGGCTGGTAGTTACCAAATCAGGGTTAAGAAACATCAGGGCCACATTTCACTACCTTCACAGATCAAACTCAGCAGCAG TCATGACTGTCTGTCACTACACTGGGGATCCCAATTCCACATAAGCACTTTTGGAAGAAAACAGCCAAAGTTGGCCTAAAATTGGCGCTG GAATTTGGGCTGGGAAAAATCTTGTGGTTATTTCCTTTAAAAAGGAACAAAACTTTAGTATTTAATTAGTTGATTTATTTAATGTAATTT >8563_8563_1_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000262320_MYO19_chr17_34867294_ENST00000268852_length(amino acids)=1007AA_BP=535 MPPPEPAGVGPEPRPRGAGGWELAAGPLRRPRGLPRVRLRAAEPQPPRWGPPRAAPPPGPARRAAAERMGPDRAAPLREPGPGSRHHRAR DRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPASYSFCSGKGVGIKGETSTATPRR SDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCDSNEEKRLKLARAIYRKYILDNN GIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVCSDQSSGSGTGKGISGYLPTLNE DEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYALAPATSANDSEQQSLSSDADTL SLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQRTREAEEKLEERLKRVRMVLAGL LHLGNIQFAASEDEAQPCQPMDDAKYSVRTAASLLGLPEDVLLEMVQIRTIRAGRQQQVFRKPCARAECDTRRDCLAKLIYARLFDWLVS VINSSICADTDSWTTFIGLLDVYGFESFPDNSLEQLCINYANEKLQLEACGLVETIHISAAGFPIRVSHRNFVERYKLLRRLHPCTSSGP DSPYPAKGLPEWCPHSEEATLEPLIQDILHTLPVLTQAAAITGDSAEAMPAPMHCGRTKVFMTDSMLELLECGRARVLEQCARCIQGGWR RHRHREQERQWRAVMLIQAAIRSWLTRKHIQRLHAAATVIKRAWQKWRIRMACLAAKELDGVEEKHFSQAPCSLSTSPLQTRLLEAIIRL WPLGLVLANTAMGVGSFQRKLVVWACLQLPRGSPSSYTVQTAQDQAGVTSIRALPQGSIKFHCRKSPLRYADICPEPSPYSITGFNQILL -------------------------------------------------------------- >8563_8563_2_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000262320_MYO19_chr17_34867294_ENST00000431794_length(transcript)=4263nt_BP=1626nt CTCGGGAGGCGATCGTGGCCGCTGCCGCCGCCAGAGCCGGCCGGAGTCGGCCCGGAGCCGCGTCCACGCGGAGCGGGCGGGTGGGAGCTG GCGGCTGGGCCCCTGCGGCGCCCCCGCGGCCTGCCCCGCGTCCGCCTCCGGGCCGCCGAGCCGCAGCCGCCGAGATGGGGGCCGCCCCGG GCCGCGCCCCCGCCGGGTCCCGCCCGCCGCGCTGCCGCTGAGCGCATGGGCCCGGACCGCGCCGCGCCGCTCCGGGAGCCGGGCCCGGGG TCCCGCCACCACCGCGCGCGGGACAGATTGATTCACTTTGGAGCTGTAAGTACTGATGTATTAGGGTGCAGCGCTCATTGTTCCTTGACG CAGAGTCCCAAAATGAATATCCAAGAGCAGGGTTTCCCCTTGGACCTCGGAGCAAGTTTCACCGAAGATGCTCCCCGACCCCCAGTGCCT GGTGAGGAGGGAGAACTGGTGTCCACAGACCCGAGGCCCGCCAGCTACAGTTTCTGCTCCGGGAAAGGTGTTGGCATTAAAGGTGAGACT TCGACGGCCACTCCGAGGCGCTCGGATCTGGACCTGGGGTATGAGCCTGAGGGCAGTGCCTCCCCCACCCCACCATACTTGAAGTGGGCT GAGTCACTGCATTCCCTGCTGGATGACCAAGATGGGATAAGCCTGTTCAGGACTTTCCTGAAGCAGGAGGGCTGTGCCGACTTGCTGGAC TTCTGGTTTGCCTGCACTGGCTTCAGGAAGCTGGAGCCCTGTGACTCGAACGAGGAGAAGAGGCTGAAGCTGGCGAGAGCCATCTACCGA AAGTACATTCTTGATAACAATGGCATCGTGTCCCGGCAGACCAAGCCAGCCACCAAGAGCTTCATAAAGGGCTGCATCATGAAGCAGCTG ATCGATCCTGCCATGTTTGACCAGGCCCAGACCGAAATCCAGGCCACTATGGAGGAAAACACCTATCCCTCCTTCCTTAAGTCTGATATT TATTTGGAATATACGAGGACAGGCTCGGAGAGCCCCAAAGTCTGTAGTGACCAGAGCTCTGGGTCAGGGACAGGGAAGGGCATATCTGGA TACCTGCCGACCTTAAATGAAGATGAGGAATGGAAGTGTGACCAGGACATGGATGAGGACGATGGCAGAGACGCTGCTCCCCCCGGAAGA CTCCCTCAGAAGCTGCTCCTGGAGACAGCTGCCCCGAGGGTCTCCTCCAGTAGACGGTACAGCGAAGGCAGAGAGTTCAGGTATGGATCC TGGCGGGAGCCAGTCAACCCCTATTATGTCAATGCCGGCTATGCCCTGGCCCCAGCCACCAGTGCCAACGACAGCGAGCAGCAGAGCCTG TCCAGCGATGCAGACACCCTGTCCCTCACGGACAGCAGCGTGGATGGGATCCCCCCATACAGGATCCGTAAGCAGCACCGCAGGGAGATG CAGGAGAGCGTGCAGGTCAATGGGCGGGTGCCCCTACCTCACATTCCCCGCACGTACCGGGTGCCGAAGGAGGTCCGCGTGGAGCCTCAG AAGTTCGCGGAGGAGCTCATCCACCGCCTGGAGGCTGTGCAGCGCACGCGGGAGGCCGAGGAGAAGCTGGAGGAGCGGCTGAAGCGCGTG CGCATGGTCCTAGCTGGACTGCTGCACCTTGGCAATATCCAGTTTGCTGCCTCCGAGGATGAAGCCCAGCCCTGCCAGCCGATGGATGAT GCCAAGTACTCTGTCAGGACGGCAGCCTCGCTGCTGGGGCTCCCAGAGGACGTGCTGCTGGAGATGGTGCAGATTAGAACCATCAGGGCA GGCAGACAGCAGCAGGTGTTCCGGAAGCCCTGCGCCCGAGCCGAGTGTGACACCCGTAGAGACTGCCTGGCCAAACTGATCTATGCGCGG TTGTTTGACTGGCTGGTATCAGTGATCAACAGCAGCATCTGTGCAGACACCGACTCGTGGACCACTTTCATAGGCCTGCTGGATGTGTAT GGATTTGAATCATTTCCTGACAACAGTCTGGAACAGTTGTGCATCAACTACGCCAATGAGAAGCTGCAGCAGCATTTTGTGGCTCACTAC CTAAGGGCCCAGCAGGAGGAATACGCAGTTGAGGGCCTGGAGTGGTCATTCATCAACTACCAGGACAACCAGCCCTGTTTGGATCTCATT GAGGGAAGCCCCATCAGCATCTGCTCCCTCATAAATGAGGAATGCCGCCTCAATCGACCCAGCAGCGCAGCCCAGCTCCAGACACGCATT GAGACTGCCCTGGCAGGCAGCCCCTGCCTGGGCCACAATAAGCTCAGCCGGGAGCCCAGCTTCATTGTGGTGCATTATGCGGGGCCTGTG CGGTACCACACAGCAGGCCTGGTGGAGAAGAACAAGGACCCTATCCCACCTGAGCTGACCAGGCTCCTGCAGCAATCCCAGGACCCCCTG CTCATGGGGCTGTTTCCTACTAACCCCAAAGAGAAGACCCAGGAGGAACCCCCTGGCCAGAGCAGGGCCCCTGTGTTGACCGTGGTGTCC AAGTTCAAGGCCTCACTGGAGCAGCTTCTGCAGGTCCTACACAGCACCACGCCCCACTACATTCGCTGCATCAAGCCCAACAGCCAGGGC CAGGCGCAGACCTTTCTCCAAGAGGAGGTCCTGAGCCAGCTGGAGGCCTGTGGCCTCGTGGAGACCATCCATATCAGTGCTGCTGGCTTC CCCATCCGGGTCTCTCACCGAAACTTTGTAGAACGATACAAGTTACTAAGAAGGCTTCATCCTTGCACATCCTCTGGCCCCGACAGCCCA TATCCTGCCAAAGGGCTCCCTGAATGGTGTCCACACAGCGAGGAAGCCACGCTTGAACCTCTCATCCAGGACATTCTCCACACTCTGCCG GTCCTAACTCAGGCAGCAGCCATAACTGGTGACTCGGCTGAGGCCATGCCAGCCCCCATGCACTGTGGCAGGACCAAGGTGTTCATGACT GACTCTATGCTGGAGCTTCTGGAATGTGGGCGTGCCCGGGTGCTGGAGCAGTGTGCCCGCTGCATCCAGGGTGGCTGGAGGCGACACCGG CACCGAGAGCAGGAGCGGCAGTGGCGGGCCGTCATGCTCATCCAGGCAGCCATTCGTTCCTGGTTAACTCGGAAACACATCCAGAGGCTG CATGCAGCTGCCACAGTCATCAAGCGTGCATGGCAGAAGTGGAGAATCAGAATGGCCTGCCTTGCTGCTAAAGAGCTGGATGGTGTGGAA GAAAAACACTTCTCTCAAGCTCCCTGTTCCCTGAGCACCTCGCCGCTGCAGACCAGGCTCCTGGAGGCAATAATCCGCCTCTGGCCCCTG GGACTGGTCCTGGCCAATACGGCTATGGGTGTAGGCAGCTTTCAGAGGAAATTAGTGGTCTGGGCTTGCCTCCAGCTCCCCAGGGGCAGC CCCAGTAGCTACACTGTCCAGACAGCACAAGACCAGGCTGGTGTCACGTCCATCCGAGCGCTGCCTCAGGGATCGATAAAGTTTCACTGC AGAAAGTCTCCACTGCGGTATGCTGACATCTGCCCTGAACCTTCACCCTACAGCATTACAGGCTTTAATCAGATTCTGCTGGAAAGACAC AGGCTGATCCACGTGACCTCTTCTGCCTTCACTGGGCTGGGGTGATCCTTGGTGCCTTTGTTTCCACAAGGCCTTTTCCTGCCCCCTGCC TTGCCAAAGACATTTAATCAGCACACAGCTGCCAGACTATTCCCACAGTGCTCCAAATGCACATGAACAACAGTGACGGCTCCAGCCTTC GACCCAGAGCCCCGTGCCCAGTGCGTCAGTGGGCCTGGGGTTCCAGGCTACATCAAGCACTGATGGTGTCAGGGCTGGTAGTTACCAAAT CAGGGTTAAGAAACATCAGGGCCACATTTCACTACCTTCACAGATCAAACTCAGCAGCAGTCATGACTGTCTGTCACTACACTGGGGATC CCAATTCCACATAAGCACTTTTGGAAGAAAACAGCCAAAGTTGGCCTAAAATTGGCGCTGGAATTTGGGCTGGGAAAAATCTTGTGGTTA TTTCCTTTAAAAAGGAACAAAACTTTAGTATTTAATTAGTTGATTTATTTAATGTAATTTCAAACAATTAAATTATGAATAATGCAATGT ACAGTAGAATCACGTTTTGATTTTATTAACACTGACCAAGTTTAACTCCATATGAAGTGTAAGCTTGATATCGTTTATGATGTCTATCAA >8563_8563_2_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000262320_MYO19_chr17_34867294_ENST00000431794_length(amino acids)=1207AA_BP=535 MPPPEPAGVGPEPRPRGAGGWELAAGPLRRPRGLPRVRLRAAEPQPPRWGPPRAAPPPGPARRAAAERMGPDRAAPLREPGPGSRHHRAR DRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPASYSFCSGKGVGIKGETSTATPRR SDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCDSNEEKRLKLARAIYRKYILDNN GIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVCSDQSSGSGTGKGISGYLPTLNE DEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYALAPATSANDSEQQSLSSDADTL SLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQRTREAEEKLEERLKRVRMVLAGL LHLGNIQFAASEDEAQPCQPMDDAKYSVRTAASLLGLPEDVLLEMVQIRTIRAGRQQQVFRKPCARAECDTRRDCLAKLIYARLFDWLVS VINSSICADTDSWTTFIGLLDVYGFESFPDNSLEQLCINYANEKLQQHFVAHYLRAQQEEYAVEGLEWSFINYQDNQPCLDLIEGSPISI CSLINEECRLNRPSSAAQLQTRIETALAGSPCLGHNKLSREPSFIVVHYAGPVRYHTAGLVEKNKDPIPPELTRLLQQSQDPLLMGLFPT NPKEKTQEEPPGQSRAPVLTVVSKFKASLEQLLQVLHSTTPHYIRCIKPNSQGQAQTFLQEEVLSQLEACGLVETIHISAAGFPIRVSHR NFVERYKLLRRLHPCTSSGPDSPYPAKGLPEWCPHSEEATLEPLIQDILHTLPVLTQAAAITGDSAEAMPAPMHCGRTKVFMTDSMLELL ECGRARVLEQCARCIQGGWRRHRHREQERQWRAVMLIQAAIRSWLTRKHIQRLHAAATVIKRAWQKWRIRMACLAAKELDGVEEKHFSQA PCSLSTSPLQTRLLEAIIRLWPLGLVLANTAMGVGSFQRKLVVWACLQLPRGSPSSYTVQTAQDQAGVTSIRALPQGSIKFHCRKSPLRY -------------------------------------------------------------- >8563_8563_3_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000354866_MYO19_chr17_34867294_ENST00000268852_length(transcript)=3331nt_BP=1416nt GCTGCCGCTGAGCGCATGGGCCCGGACCGCGCCGCGCCGCTCCGGGAGCCGGGCCCGGGGTCCCGCCACCACCGCGCGCGGGACAGATTG ATTCACTTTGGAGCTGTAAGTACTGATGTATTAGGGTGCAGCGCTCATTGTTCCTTGACGCAGAGTCCCAAAATGAATATCCAAGAGCAG GGTTTCCCCTTGGACCTCGGAGCAAGTTTCACCGAAGATGCTCCCCGACCCCCAGTGCCTGGTGAGGAGGGAGAACTGGTGTCCACAGAC CCGAGGCCCGCCAGCTACAGTTTCTGCTCCGGGAAAGGTGTTGGCATTAAAGGTGAGACTTCGACGGCCACTCCGAGGCGCTCGGATCTG GACCTGGGGTATGAGCCTGAGGGCAGTGCCTCCCCCACCCCACCATACTTGAAGTGGGCTGAGTCACTGCATTCCCTGCTGGATGACCAA GATGGGATAAGCCTGTTCAGGACTTTCCTGAAGCAGGAGGGCTGTGCCGACTTGCTGGACTTCTGGTTTGCCTGCACTGGCTTCAGGAAG CTGGAGCCCTGTGACTCGAACGAGGAGAAGAGGCTGAAGCTGGCGAGAGCCATCTACCGAAAGTACATTCTTGATAACAATGGCATCGTG TCCCGGCAGACCAAGCCAGCCACCAAGAGCTTCATAAAGGGCTGCATCATGAAGCAGCTGATCGATCCTGCCATGTTTGACCAGGCCCAG ACCGAAATCCAGGCCACTATGGAGGAAAACACCTATCCCTCCTTCCTTAAGTCTGATATTTATTTGGAATATACGAGGACAGGCTCGGAG AGCCCCAAAGTCTGTAGTGACCAGAGCTCTGGGTCAGGGACAGGGAAGGGCATATCTGGATACCTGCCGACCTTAAATGAAGATGAGGAA TGGAAGTGTGACCAGGACATGGATGAGGACGATGGCAGAGACGCTGCTCCCCCCGGAAGACTCCCTCAGAAGCTGCTCCTGGAGACAGCT GCCCCGAGGGTCTCCTCCAGTAGACGGTACAGCGAAGGCAGAGAGTTCAGGTATGGATCCTGGCGGGAGCCAGTCAACCCCTATTATGTC AATGCCGGCTATGCCCTGGCCCCAGCCACCAGTGCCAACGACAGCGAGCAGCAGAGCCTGTCCAGCGATGCAGACACCCTGTCCCTCACG GACAGCAGCGTGGATGGGATCCCCCCATACAGGATCCGTAAGCAGCACCGCAGGGAGATGCAGGAGAGCGTGCAGGTCAATGGGCGGGTG CCCCTACCTCACATTCCCCGCACGTACCGGGTGCCGAAGGAGGTCCGCGTGGAGCCTCAGAAGTTCGCGGAGGAGCTCATCCACCGCCTG GAGGCTGTGCAGCGCACGCGGGAGGCCGAGGAGAAGCTGGAGGAGCGGCTGAAGCGCGTGCGCATGGTCCTAGCTGGACTGCTGCACCTT GGCAATATCCAGTTTGCTGCCTCCGAGGATGAAGCCCAGCCCTGCCAGCCGATGGATGATGCCAAGTACTCTGTCAGGACGGCAGCCTCG CTGCTGGGGCTCCCAGAGGACGTGCTGCTGGAGATGGTGCAGATTAGAACCATCAGGGCAGGCAGACAGCAGCAGGTGTTCCGGAAGCCC TGCGCCCGAGCCGAGTGTGACACCCGTAGAGACTGCCTGGCCAAACTGATCTATGCGCGGTTGTTTGACTGGCTGGTATCAGTGATCAAC AGCAGCATCTGTGCAGACACCGACTCGTGGACCACTTTCATAGGCCTGCTGGATGTGTATGGATTTGAATCATTTCCTGACAACAGTCTG GAACAGTTGTGCATCAACTACGCCAATGAGAAGCTCCAGCTGGAGGCCTGTGGCCTCGTGGAGACCATCCATATCAGTGCTGCTGGCTTC CCCATCCGGGTCTCTCACCGAAACTTTGTAGAACGATACAAGTTACTAAGAAGGCTTCATCCTTGCACATCCTCTGGCCCCGACAGCCCA TATCCTGCCAAAGGGCTCCCTGAATGGTGTCCACACAGCGAGGAAGCCACGCTTGAACCTCTCATCCAGGACATTCTCCACACTCTGCCG GTCCTAACTCAGGCAGCAGCCATAACTGGTGACTCGGCTGAGGCCATGCCAGCCCCCATGCACTGTGGCAGGACCAAGGTGTTCATGACT GACTCTATGCTGGAGCTTCTGGAATGTGGGCGTGCCCGGGTGCTGGAGCAGTGTGCCCGCTGCATCCAGGGTGGCTGGAGGCGACACCGG CACCGAGAGCAGGAGCGGCAGTGGCGGGCCGTCATGCTCATCCAGGCAGCCATTCGTTCCTGGTTAACTCGGAAACACATCCAGAGGCTG CATGCAGCTGCCACAGTCATCAAGCGTGCATGGCAGAAGTGGAGAATCAGAATGGCCTGCCTTGCTGCTAAAGAGCTGGATGGTGTGGAA GAAAAACACTTCTCTCAAGCTCCCTGTTCCCTGAGCACCTCGCCGCTGCAGACCAGGCTCCTGGAGGCAATAATCCGCCTCTGGCCCCTG GGACTGGTCCTGGCCAATACGGCTATGGGTGTAGGCAGCTTTCAGAGGAAATTAGTGGTCTGGGCTTGCCTCCAGCTCCCCAGGGGCAGC CCCAGTAGCTACACTGTCCAGACAGCACAAGACCAGGCTGGTGTCACGTCCATCCGAGCGCTGCCTCAGGGATCGATAAAGTTTCACTGC AGAAAGTCTCCACTGCGGTATGCTGACATCTGCCCTGAACCTTCACCCTACAGCATTACAGGCTTTAATCAGATTCTGCTGGAAAGACAC AGGCTGATCCACGTGACCTCTTCTGCCTTCACTGGGCTGGGGTGATCCTTGGTGCCTTTGTTTCCACAAGGCCTTTTCCTGCCCCCTGCC TTGCCAAAGACATTTAATCAGCACACAGCTGCCAGACTATTCCCACAGTGCTCCAAATGCACATGAACAACAGTGACGGCTCCAGCCTTC GACCCAGAGCCCCGTGCCCAGTGCGTCAGTGGGCCTGGGGTTCCAGGCTACATCAAGCACTGATGGTGTCAGGGCTGGTAGTTACCAAAT CAGGGTTAAGAAACATCAGGGCCACATTTCACTACCTTCACAGATCAAACTCAGCAGCAGTCATGACTGTCTGTCACTACACTGGGGATC CCAATTCCACATAAGCACTTTTGGAAGAAAACAGCCAAAGTTGGCCTAAAATTGGCGCTGGAATTTGGGCTGGGAAAAATCTTGTGGTTA TTTCCTTTAAAAAGGAACAAAACTTTAGTATTTAATTAGTTGATTTATTTAATGTAATTTCAAACAATTAAATTATGAATAATGCAATGT >8563_8563_3_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000354866_MYO19_chr17_34867294_ENST00000268852_length(amino acids)=939AA_BP=467 MGPDRAAPLREPGPGSRHHRARDRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPAS YSFCSGKGVGIKGETSTATPRRSDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCD SNEEKRLKLARAIYRKYILDNNGIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVC SDQSSGSGTGKGISGYLPTLNEDEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYA LAPATSANDSEQQSLSSDADTLSLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQR TREAEEKLEERLKRVRMVLAGLLHLGNIQFAASEDEAQPCQPMDDAKYSVRTAASLLGLPEDVLLEMVQIRTIRAGRQQQVFRKPCARAE CDTRRDCLAKLIYARLFDWLVSVINSSICADTDSWTTFIGLLDVYGFESFPDNSLEQLCINYANEKLQLEACGLVETIHISAAGFPIRVS HRNFVERYKLLRRLHPCTSSGPDSPYPAKGLPEWCPHSEEATLEPLIQDILHTLPVLTQAAAITGDSAEAMPAPMHCGRTKVFMTDSMLE LLECGRARVLEQCARCIQGGWRRHRHREQERQWRAVMLIQAAIRSWLTRKHIQRLHAAATVIKRAWQKWRIRMACLAAKELDGVEEKHFS QAPCSLSTSPLQTRLLEAIIRLWPLGLVLANTAMGVGSFQRKLVVWACLQLPRGSPSSYTVQTAQDQAGVTSIRALPQGSIKFHCRKSPL -------------------------------------------------------------- >8563_8563_4_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000354866_MYO19_chr17_34867294_ENST00000431794_length(transcript)=4053nt_BP=1416nt GCTGCCGCTGAGCGCATGGGCCCGGACCGCGCCGCGCCGCTCCGGGAGCCGGGCCCGGGGTCCCGCCACCACCGCGCGCGGGACAGATTG ATTCACTTTGGAGCTGTAAGTACTGATGTATTAGGGTGCAGCGCTCATTGTTCCTTGACGCAGAGTCCCAAAATGAATATCCAAGAGCAG GGTTTCCCCTTGGACCTCGGAGCAAGTTTCACCGAAGATGCTCCCCGACCCCCAGTGCCTGGTGAGGAGGGAGAACTGGTGTCCACAGAC CCGAGGCCCGCCAGCTACAGTTTCTGCTCCGGGAAAGGTGTTGGCATTAAAGGTGAGACTTCGACGGCCACTCCGAGGCGCTCGGATCTG GACCTGGGGTATGAGCCTGAGGGCAGTGCCTCCCCCACCCCACCATACTTGAAGTGGGCTGAGTCACTGCATTCCCTGCTGGATGACCAA GATGGGATAAGCCTGTTCAGGACTTTCCTGAAGCAGGAGGGCTGTGCCGACTTGCTGGACTTCTGGTTTGCCTGCACTGGCTTCAGGAAG CTGGAGCCCTGTGACTCGAACGAGGAGAAGAGGCTGAAGCTGGCGAGAGCCATCTACCGAAAGTACATTCTTGATAACAATGGCATCGTG TCCCGGCAGACCAAGCCAGCCACCAAGAGCTTCATAAAGGGCTGCATCATGAAGCAGCTGATCGATCCTGCCATGTTTGACCAGGCCCAG ACCGAAATCCAGGCCACTATGGAGGAAAACACCTATCCCTCCTTCCTTAAGTCTGATATTTATTTGGAATATACGAGGACAGGCTCGGAG AGCCCCAAAGTCTGTAGTGACCAGAGCTCTGGGTCAGGGACAGGGAAGGGCATATCTGGATACCTGCCGACCTTAAATGAAGATGAGGAA TGGAAGTGTGACCAGGACATGGATGAGGACGATGGCAGAGACGCTGCTCCCCCCGGAAGACTCCCTCAGAAGCTGCTCCTGGAGACAGCT GCCCCGAGGGTCTCCTCCAGTAGACGGTACAGCGAAGGCAGAGAGTTCAGGTATGGATCCTGGCGGGAGCCAGTCAACCCCTATTATGTC AATGCCGGCTATGCCCTGGCCCCAGCCACCAGTGCCAACGACAGCGAGCAGCAGAGCCTGTCCAGCGATGCAGACACCCTGTCCCTCACG GACAGCAGCGTGGATGGGATCCCCCCATACAGGATCCGTAAGCAGCACCGCAGGGAGATGCAGGAGAGCGTGCAGGTCAATGGGCGGGTG CCCCTACCTCACATTCCCCGCACGTACCGGGTGCCGAAGGAGGTCCGCGTGGAGCCTCAGAAGTTCGCGGAGGAGCTCATCCACCGCCTG GAGGCTGTGCAGCGCACGCGGGAGGCCGAGGAGAAGCTGGAGGAGCGGCTGAAGCGCGTGCGCATGGTCCTAGCTGGACTGCTGCACCTT GGCAATATCCAGTTTGCTGCCTCCGAGGATGAAGCCCAGCCCTGCCAGCCGATGGATGATGCCAAGTACTCTGTCAGGACGGCAGCCTCG CTGCTGGGGCTCCCAGAGGACGTGCTGCTGGAGATGGTGCAGATTAGAACCATCAGGGCAGGCAGACAGCAGCAGGTGTTCCGGAAGCCC TGCGCCCGAGCCGAGTGTGACACCCGTAGAGACTGCCTGGCCAAACTGATCTATGCGCGGTTGTTTGACTGGCTGGTATCAGTGATCAAC AGCAGCATCTGTGCAGACACCGACTCGTGGACCACTTTCATAGGCCTGCTGGATGTGTATGGATTTGAATCATTTCCTGACAACAGTCTG GAACAGTTGTGCATCAACTACGCCAATGAGAAGCTGCAGCAGCATTTTGTGGCTCACTACCTAAGGGCCCAGCAGGAGGAATACGCAGTT GAGGGCCTGGAGTGGTCATTCATCAACTACCAGGACAACCAGCCCTGTTTGGATCTCATTGAGGGAAGCCCCATCAGCATCTGCTCCCTC ATAAATGAGGAATGCCGCCTCAATCGACCCAGCAGCGCAGCCCAGCTCCAGACACGCATTGAGACTGCCCTGGCAGGCAGCCCCTGCCTG GGCCACAATAAGCTCAGCCGGGAGCCCAGCTTCATTGTGGTGCATTATGCGGGGCCTGTGCGGTACCACACAGCAGGCCTGGTGGAGAAG AACAAGGACCCTATCCCACCTGAGCTGACCAGGCTCCTGCAGCAATCCCAGGACCCCCTGCTCATGGGGCTGTTTCCTACTAACCCCAAA GAGAAGACCCAGGAGGAACCCCCTGGCCAGAGCAGGGCCCCTGTGTTGACCGTGGTGTCCAAGTTCAAGGCCTCACTGGAGCAGCTTCTG CAGGTCCTACACAGCACCACGCCCCACTACATTCGCTGCATCAAGCCCAACAGCCAGGGCCAGGCGCAGACCTTTCTCCAAGAGGAGGTC CTGAGCCAGCTGGAGGCCTGTGGCCTCGTGGAGACCATCCATATCAGTGCTGCTGGCTTCCCCATCCGGGTCTCTCACCGAAACTTTGTA GAACGATACAAGTTACTAAGAAGGCTTCATCCTTGCACATCCTCTGGCCCCGACAGCCCATATCCTGCCAAAGGGCTCCCTGAATGGTGT CCACACAGCGAGGAAGCCACGCTTGAACCTCTCATCCAGGACATTCTCCACACTCTGCCGGTCCTAACTCAGGCAGCAGCCATAACTGGT GACTCGGCTGAGGCCATGCCAGCCCCCATGCACTGTGGCAGGACCAAGGTGTTCATGACTGACTCTATGCTGGAGCTTCTGGAATGTGGG CGTGCCCGGGTGCTGGAGCAGTGTGCCCGCTGCATCCAGGGTGGCTGGAGGCGACACCGGCACCGAGAGCAGGAGCGGCAGTGGCGGGCC GTCATGCTCATCCAGGCAGCCATTCGTTCCTGGTTAACTCGGAAACACATCCAGAGGCTGCATGCAGCTGCCACAGTCATCAAGCGTGCA TGGCAGAAGTGGAGAATCAGAATGGCCTGCCTTGCTGCTAAAGAGCTGGATGGTGTGGAAGAAAAACACTTCTCTCAAGCTCCCTGTTCC CTGAGCACCTCGCCGCTGCAGACCAGGCTCCTGGAGGCAATAATCCGCCTCTGGCCCCTGGGACTGGTCCTGGCCAATACGGCTATGGGT GTAGGCAGCTTTCAGAGGAAATTAGTGGTCTGGGCTTGCCTCCAGCTCCCCAGGGGCAGCCCCAGTAGCTACACTGTCCAGACAGCACAA GACCAGGCTGGTGTCACGTCCATCCGAGCGCTGCCTCAGGGATCGATAAAGTTTCACTGCAGAAAGTCTCCACTGCGGTATGCTGACATC TGCCCTGAACCTTCACCCTACAGCATTACAGGCTTTAATCAGATTCTGCTGGAAAGACACAGGCTGATCCACGTGACCTCTTCTGCCTTC ACTGGGCTGGGGTGATCCTTGGTGCCTTTGTTTCCACAAGGCCTTTTCCTGCCCCCTGCCTTGCCAAAGACATTTAATCAGCACACAGCT GCCAGACTATTCCCACAGTGCTCCAAATGCACATGAACAACAGTGACGGCTCCAGCCTTCGACCCAGAGCCCCGTGCCCAGTGCGTCAGT GGGCCTGGGGTTCCAGGCTACATCAAGCACTGATGGTGTCAGGGCTGGTAGTTACCAAATCAGGGTTAAGAAACATCAGGGCCACATTTC ACTACCTTCACAGATCAAACTCAGCAGCAGTCATGACTGTCTGTCACTACACTGGGGATCCCAATTCCACATAAGCACTTTTGGAAGAAA ACAGCCAAAGTTGGCCTAAAATTGGCGCTGGAATTTGGGCTGGGAAAAATCTTGTGGTTATTTCCTTTAAAAAGGAACAAAACTTTAGTA TTTAATTAGTTGATTTATTTAATGTAATTTCAAACAATTAAATTATGAATAATGCAATGTACAGTAGAATCACGTTTTGATTTTATTAAC ACTGACCAAGTTTAACTCCATATGAAGTGTAAGCTTGATATCGTTTATGATGTCTATCAACTGTACCAAAAGTAAAACATTTAAAAACAA >8563_8563_4_AXIN1-MYO19_AXIN1_chr16_354304_ENST00000354866_MYO19_chr17_34867294_ENST00000431794_length(amino acids)=1139AA_BP=467 MGPDRAAPLREPGPGSRHHRARDRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPAS YSFCSGKGVGIKGETSTATPRRSDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCD SNEEKRLKLARAIYRKYILDNNGIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVC SDQSSGSGTGKGISGYLPTLNEDEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYA LAPATSANDSEQQSLSSDADTLSLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQR TREAEEKLEERLKRVRMVLAGLLHLGNIQFAASEDEAQPCQPMDDAKYSVRTAASLLGLPEDVLLEMVQIRTIRAGRQQQVFRKPCARAE CDTRRDCLAKLIYARLFDWLVSVINSSICADTDSWTTFIGLLDVYGFESFPDNSLEQLCINYANEKLQQHFVAHYLRAQQEEYAVEGLEW SFINYQDNQPCLDLIEGSPISICSLINEECRLNRPSSAAQLQTRIETALAGSPCLGHNKLSREPSFIVVHYAGPVRYHTAGLVEKNKDPI PPELTRLLQQSQDPLLMGLFPTNPKEKTQEEPPGQSRAPVLTVVSKFKASLEQLLQVLHSTTPHYIRCIKPNSQGQAQTFLQEEVLSQLE ACGLVETIHISAAGFPIRVSHRNFVERYKLLRRLHPCTSSGPDSPYPAKGLPEWCPHSEEATLEPLIQDILHTLPVLTQAAAITGDSAEA MPAPMHCGRTKVFMTDSMLELLECGRARVLEQCARCIQGGWRRHRHREQERQWRAVMLIQAAIRSWLTRKHIQRLHAAATVIKRAWQKWR IRMACLAAKELDGVEEKHFSQAPCSLSTSPLQTRLLEAIIRLWPLGLVLANTAMGVGSFQRKLVVWACLQLPRGSPSSYTVQTAQDQAGV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for AXIN1-MYO19 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 209_338 | 418.0 | 863.0 | TP53 |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 209_338 | 418.0 | 827.0 | TP53 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 434_502 | 418.0 | 863.0 | CTNNB1 |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 434_502 | 418.0 | 827.0 | CTNNB1 |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 348_433 | 418.0 | 863.0 | GSK3B |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 348_433 | 418.0 | 827.0 | GSK3B |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 677_752 | 418.0 | 863.0 | HIPK2 |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 677_752 | 418.0 | 827.0 | HIPK2 |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 575_789 | 418.0 | 863.0 | PPP2CA |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 575_789 | 418.0 | 827.0 | PPP2CA |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000262320 | - | 5 | 11 | 507_757 | 418.0 | 863.0 | RNF111 |
Hgene | AXIN1 | chr16:354304 | chr17:34867294 | ENST00000354866 | - | 5 | 10 | 507_757 | 418.0 | 827.0 | RNF111 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AXIN1-MYO19 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for AXIN1-MYO19 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | AXIN1 | C2239176 | Liver carcinoma | 2 | CGI;CTD_human;UNIPROT |
Hgene | AXIN1 | C0279607 | Adult Hepatocellular Carcinoma | 1 | ORPHANET |